Serna Bio is an early stage AI enabled biotech combining in vitro assays and in silico models to discover small molecules targeting RNA.

Meet CEO and Founder Dr Rabia Khan, in our short CEO Spotlight video below. Rabia discusses why Serna Bio was founded, and how the company is using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions.